MedTrace Logo

CPR Prediction After Neoadjuvant Using Excisional Biopsy By Radiofrequency In Breast Cancer From II-III UICC Stages.

NCT01984866 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 13

Last updated 2020-08-11

No results posted yet for this study

Summary

This project aims to determine whether biopsy using radiofrequency is a procedure suitable for this patient selection. Findings from biopsy will be correlated with the conventional surgery ones. If the technique is validated to predict the presence or absence of residual tumor, breast surgery could be avoided in cases of absence of tumor.

Conditions

  • Triple Negative, HER2+, Luminal B Breast Tumors (Stages II-III)in Female Patients

Sponsors & Collaborators

  • Hospital General Universitario Gregorio Marañon

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2018-04-30
Completion
2018-08-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01984866 on ClinicalTrials.gov